TJRBiosciences is a biopharmaceutical company that focuses on developing innovative therapies for cancer patients. Their two flagship products are the next-generation Bcr-Abl allosteric inhibitor TGRX- with a novel mechanism for the treatment of chronic myelogenous leukemia (CML), and the third-generation ALK inhibitor TGRX- for the treatment of non-small cell lung cancer (NSCLC) 1. They also have a partnering program for interested parties 2.
However, if you have any specific questions about their products or services, I’d be happy to help you find that information.
Member count: 11-50
Founded date: 2014
Investors 1
| Date | Name | Website |
| - | HONGTAI Ap... | apluscap.c... |